Edap Tms (EDAP) Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" EDAP shares.
View EDAP analyst ratings or view top-rated stocks.

2 Wall Street research analysts have issued 12 month price targets for Edap Tms' shares. Their EDAP share price forecasts range from $11.00 to $16.00. On average, they expect the company's stock price to reach $13.75 in the next twelve months. This suggests a possible upside of 38.1% from the stock's current price.
View analysts price targets for EDAP or view top-rated stocks among Wall Street analysts.

Edap Tms' stock was trading at $10.66 at the start of the year. Since then, EDAP shares have decreased by 6.6% and is now trading at $9.96.
View the best growth stocks for 2023 here.

Edap Tms saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 38,400 shares, an increase of 23.9% from the April 30th total of 31,000 shares. Based on an average daily volume of 66,100 shares, the short-interest ratio is currently 0.6 days.
View Edap Tms' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 23rd 2023.
View our EDAP earnings forecast.

Edap Tms S.A. (NASDAQ:EDAP) posted its quarterly earnings data on Thursday, March, 30th. The medical equipment provider reported ($0.14) earnings per share for the quarter, missing the consensus estimate of $0.01 by $0.15. The medical equipment provider earned $16.19 million during the quarter, compared to analyst estimates of $16.55 million. Edap Tms had a negative trailing twelve-month return on equity of 16.56% and a negative net margin of 19.22%.

Inspire Fidelis Multi Factor ETF holds 44,798 shares of EDAP stock, representing 0.95% of its portfolio.

Based on aggregate information from My MarketBeat watchlists, some companies that other Edap Tms investors own include Energous (WATT), Weatherford International (WFT), CTI BioPharma (CTIC), Petróleo Brasileiro S.A. - Petrobras (PBR), Kandi Technologies Group (KNDI), Misonix (MSON), Achillion Pharmaceuticals (ACHN), Advanced Micro Devices (AMD), Destination Maternity (DESTQ) and Pacific Drilling (PACDQ).

Edap Tms trades on the NASDAQ under the ticker symbol "EDAP."

Edap Tms' stock is owned by many different institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (1.18%), Federated Hermes Inc. (1.10%), Acadian Asset Management LLC (0.77%), Envestnet Asset Management Inc. (0.63%), Susquehanna International Group LLP (0.00%) and O Shaughnessy Asset Management LLC (0.24%).

Shares of EDAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EDAP stock can currently be purchased for approximately $9.96.

Edap Tms (NASDAQ:EDAP) has a market capitalization of $367.62 million and generates $57.97 million in revenue each year. The medical equipment provider earns $-3,090,000.00 in net income (profit) each year or ($0.30) on an earnings per share basis.

The company employs 223 workers across the globe.

Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The official website for the company is www.edap-tms.com. The medical equipment provider can be reached via phone at (347) 215-3150, via email at bconfort@edap-tms.com, or via fax at 33-04-72-15-31-51.